ArticleMolecular biology reports2026
Pyranocoumarin-enriched residue extracts of Angelica gigas suppress NLRP3 inflammasome activation and neuroinflammation.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAngelica gigas Nakai is a medicinal plant rich in pyranocoumarins with well-documented anti-inflammatory and neuroprotective properties. However, the pharmacological potential of residues remaining after conventional aqueous extraction remains largely unexplored. This study investigated the phytochemical composition and anti-neuroinflammatory activity of residue-derived extracts of A. gigas, focusing on the regulation of the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome. METHODS AND
resultsA water extract (PO6W), an ethanol extract (PO6E), and a residue-derived ethanol extract (PO6RE) were chemically characterized and evaluated in lipopolysaccharide-stimulated BV2 microglial cells and an LPS-induced mouse model. Molecular docking, surface plasmon resonance, and MCC950 intervention were used to investigate the association between decursin and NLRP3 signaling. Despite prior aqueous extraction, the residual biomass retained substantial amounts of pyranocoumarins, and subsequent ethanol extraction yielded PO6RE with the highest levels of decursin and decursinol angelate. PO6RE significantly suppressed the expression levels of NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain, cleaved caspase-1, and interleukin-1β in BV2 cells and reduced microglial activation in vivo. Decursin showed measurable binding to NLRP3 and reduced NLRP3 expression and interleukin-1β production.
conclusionsA. gigas biomass remaining after aqueous extraction retains bioactive pyranocoumarins that can be recovered by subsequent ethanol extraction. The resulting residue-derived extract exhibited anti-neuroinflammatory activity associated with NLRP3 inflammasome signaling, highlighting extraction residues as an underutilized and potentially sustainable source of bioactive phytochemicals.
Indexed as
Identifiers
42886278What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.